Varaico: Literature-Extracted Genetic Variants

Gene:GSTP1
Variant:p.A114V
Back to variants list

GSTP1

NM_000852.4:p.A114V

Associated Papers

Polymorphism and transcriptional regulation of GSTP1 in cancer and other human diseases.

Zeng QR et al.

International Journal of Biological Macromolecules, 2026

Association of GSTP1, GSTM1, and GSTT1 polymorphisms with Diisocyanate-induced asthma in Iraqi Arab male workers.

Kudhair BK et al.

Molecular Biology Reports, 2025

Single Nucleotide Polymorphisms in Oxidative Stress-Related Genes Are Associated with Autism Spectrum Disorders.

Spoto G et al.

International Journal of Molecular Sciences, 2025

Risk of Cardiovascular Complications Among Type 2 Diabetes Mellitus Patients with GSTP1 Genetic Polymorphism: A Nested Case-Control Study and Docking Studies.

Sobha SP et al.

Biochemical Genetics, 2025

SNP's use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic.

Moustafa HAM et al.

Functional & Integrative Genomics, 2025

Investigation of GSTP1 and PTEN gene polymorphisms and their association with susceptibility to colorectal cancer.

Durr-E-Shahwar et al.

Radiology and Oncology, 2025

Genetic Polymorphism of GSTM1, GSTT1, GSTP1 Genes and Breast Cancer Risk in Rural Maharashtra: Insights from a Case- Control Study.

Datkhile KD et al.

Asian Pacific Journal of Cancer Prevention : Apjcp, 2025

Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism.

Değerli E

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 2025

A Case-Control Study of the Association Between GSTP1 Gene Polymorphisms (rs1695 and rs1138272) and the Susceptibility to Male Infertility in the Moroccan Population.

Harmak H et al.

Genetic Testing and Molecular Biomarkers, 2025

The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.

Cacabelos R et al.

Expert Opinion on Drug Metabolism & Toxicology, 2025

Investigation of Genetic Polymorphisms Related GSTM1, GSTT1, GSTP1 Genes and their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients.

Gudur AK et al.

Asian Pacific Journal of Cancer Prevention : Apjcp, 2025

Comprehensive pharmacogenomics profiling of the Serbian population.

Jelovac M et al.

Frontiers in Pharmacology, 2025

40166472 (PubMed )
Supplement: DataSheet1.xlsx › 4._CES_WES

Genetic polymorphisms of antioxidant enzymes (GSTP1/CAT/HMOX1/EPHX1) and childhood asthma risk in Fuzhou.

Wu Z et al.

Frontiers in Pediatrics, 2025

dbGVOSCC: a comprehensive database of genetic variation for systems genetics research on oral squamous cell carcinoma.

Zhou Y et al.

Frontiers in Oncology, 2025

41244916 (PubMed )
Supplement: DataSheet1.docx

The association of combined GSTM1, GSTT1, and GSTP1 genetic polymorphisms with lung cancer risk in male Iraqi Waterpipe Tobacco (Nargila) smokers.

Kudhair BK et al.

Cancer Epidemiology, 2024

Chemoproteogenomic stratification of the missense variant cysteinome.

Desai H et al.

Nature Communications, 2024

Genetic Polymorphisms in Glutathione S-Transferase (GST) Gene and Their Correlation with Toxicity of Chemotherapy in Breast Cancer Patients.

Gudur RA et al.

Asian Pacific Journal of Cancer Prevention : Apjcp, 2024

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.

Patiño-García A et al.

Ebiomedicine, 2024

38484556 (PubMed )
Supplement: mmc1.xlsx › Supp_Table_2

Single-Nucleotide Polymorphisms Associated with Mercury Levels and Neurological Symptoms: An Overview.

Perini JA et al.

Toxics, 2024

38535959 (PubMed )
Supplement: toxics-12-00226-s001.zip › toxics-2905208-supplementary.pdf

Glutathione S-transferase M1, T1, and P1 polymorphisms and periodontitis in a Caucasian population: a case-control study.

Izakovicova P et al.

Bmc Oral Health, 2024

Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer.

Sito H et al.

Molecular Biology Reports, 2024

Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study.

Štampar P et al.

Frontiers in Pharmacology, 2024

Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review.

Zheng Y et al.

Frontiers in Pharmacology, 2024

Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.

Zhang T et al.

Peerj, 2024

39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT

GPX3 Variant Genotype Affects the Risk of Developing Severe Forms of COVID-19.

Markovic M et al.

International Journal of Molecular Sciences, 2023

Association between the oxidative stress gene polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis.

Zhou T et al.

Bmc Pulmonary Medicine, 2023

Multi-omic stratification of the missense variant cysteinome.

Desai H et al.

Biorxiv : the Preprint Server for Biology, 2023

GPX3 rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy.

Radic Savic Z et al.

Medicina (kaunas, Lithuania), 2023

Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer's Disease and Dementia.

Vogrinc D et al.

Antioxidants (basel, Switzerland), 2023

36829875 (PubMed )
Supplement: antioxidants-12-00316-s001.zip › antioxidants-2090948-supplementary.pdf

The GSTO2 (rs156697) Polymorphism Modifies Diabetic Nephropathy Risk.

Pavlovic D et al.

Medicina (kaunas, Lithuania), 2023

Pharmacogenetics of anxiety and depression in Alzheimer's disease.

Cacabelos R et al.

Pharmacogenomics, 2023

EPHX1 and GSTP1 polymorphisms are associated with COPD risk: a systematic review and meta-analysis.

Yang Q et al.

Frontiers in Genetics, 2023

Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling.

Deserranno K et al.

Frontiers in Pharmacology, 2023

38026945 (PubMed )
Supplement: DataSheet1.ZIP › SupplementaryMaterials › SupplementaryMaterials_Tables_S4-S9.xlsx › HG001_R10.4.1_AldyCalls

SOD2 rs4880 and GPX1 rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohort.

Jerotic D et al.

Redox Report : Communications in Free Radical Research, 2022

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.

Narendra G et al.

Clinical Pharmacokinetics, 2022

Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers.

Bignucolo A et al.

Expert Review of Clinical Pharmacology, 2022

Detoxification Role of Metabolic Glutathione S-Transferase (GST) Genes in Blood Lead Concentrations of Jamaican Children with and without Autism Spectrum Disorder.

Rahbar MH et al.

Genes, 2022

Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.

Silgado-Guzmán DF et al.

Frontiers in Pharmacology, 2022

35846994 (PubMed )
Supplement: Table1.xlsx › Hoja1

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.

Muñiz P et al.

Frontiers in Immunology, 2022

36211438 (PubMed )
Supplement: Table_1.xlsx › Hoja1

Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review.

Rajabi-Moghaddam M et al.

Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022

Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review.

Rajabi-Moghaddam M et al.

Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022

Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features.

Papasavva M et al.

Frontiers in Neurology, 2022

The relevance analysis of GSTP1 rs1695 and lung cancer in the Chinese Han population.

Xiao J et al.

The International Journal of Biological Markers, 2021

Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.

Zhang WP et al.

Medicine, 2021

34190143 (PubMed )
Supplement: medi-100-e26104-s001.pdf

Glutathione-S-transferases genes-promising predictors of hepatic dysfunction.

Prysyazhnyuk V et al.

World Journal of Hepatology, 2021

Polymorphisms in xenobiotic metabolism-related genes in patients with hepatocellular carcinoma: a case-control study.

Ferreira GD et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2021

Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype.

Atanasovska Velkovska M et al.

Journal of Clinical Medicine, 2021

33803434 (PubMed )
Supplement: jcm-10-01148-s001.pdf
1–50 of 380 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."